February 12, 2016

Emulate, Inc. Opens New Headquarters and Laboratories in the Seaport District of Boston’s Innovation Community

Emulate, Inc., announced the official opening of its new headquarters and laboratories in Boston’s Seaport District, at 27 Drydock Avenue within The Innovation and Design Building.  The new facility will be a workplace for the company’s 40 employees, with plans for expansion to 85 employees within the coming year.

Emulate located its new headquarters to facilitate collaborations within Boston’s biotechnology hub of pharmaceutical and biotech companies who are using the Organs-on-Chips technology to better predict the potential efficacy and safety of drug candidates, and to improve the drug development process.

Emulate President & CSO Geraldine Hamilton cuts the ribbon to officially open Emulate’s new headquarters in the Seaport District of Boston, joined by City, State, and industry officials including Boston City Councilor Bill Linehan (left), MassBio Chief Business Officer John Hallinan (second from left), City of Boston Economic Development Director John Barros (fourth from left), Massachusetts Life Sciences Center President & CEO Travis McCready (fifth from left), and the Baker Administration’s Assistant Secretary for Business Growth, Mike Kennealy (right).

Emulate President & CSO Geraldine Hamilton cuts the ribbon to officially open Emulate’s new headquarters in the Seaport District of Boston, joined by City, State, and industry officials including Boston City Councilor Bill Linehan (left), MassBio Chief Business Officer John Hallinan (second from left), City of Boston Economic Development Director John Barros (fourth from left), Massachusetts Life Sciences Center President & CEO Travis McCready (fifth from left), and the Baker Administration’s Assistant Secretary for Business Growth, Mike Kennealy (right).

Read the press release here »

January 28, 2016

Simcere Opens Office in Cambridge and Announces Life Sciences Startup Competition

The new expansion enables Simcere to provide additional functions to all our clients, and to be a part of one of the world’s leading ecocystems for life sciences innovation in the Greater Boston region. The company also announced that it is a sponsor for an international startup contest in life science, especially in precision medicine and e-health. The co-sponsors include influential Chinese industrial investors, pharmaceutical companies and Chinese media with the support of a powerful alliance of strategic investors. The event runs from January to May 2016. It will take place in 8 cities in both China and the US, with the US preliminaries held in San Francisco and Boston.

Read the press release here »

January 14, 2016

Massachusetts Life Sciences Center Opens New Round of Job Creation Tax Incentive Program

The Massachusetts Life Sciences Center (MLSC) announced that applications are now being accepted for a new round of the Job Creation Tax Incentive Program. The Program offers tax incentives to encourage the growth of companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. Through this year’s program, the MLSC will seek to leverage the life sciences assets that are now in place around the state, and promote growth throughout Massachusetts. Toward that end, the agency is actively encouraging applications from companies located outside of Greater Boston.

Read the press release here »

December 21, 2015

Massachusetts Life Sciences Center Announces Next Round of Life Sciences Accelerator Loan Program

The Massachusetts Life Sciences Center (MLSC), announced the launch of the twelfth round of its Accelerator Loan Program, the MLSC’s flagship investment program that provides working capital to early-stage life sciences companies.

In the new round, the Accelerator program will offer loans of up to $750,000 per company.  The program seeks to provide support to companies at a critical stage of their development cycle, enabling them to conduct vital research and proof of concept studies, and attract subsequent investment while improving the odds of bringing cutting-edge innovation to the marketplace.

Read the press release here »

December 16, 2015

Massachusetts Life Sciences Center Announces Six New Grants to Support R&D Collaborations

The Massachusetts Life Sciences Center (MLSC) today announced six new grants totaling $930,000 to Massachusetts companies to support R&D collaborations through the agency’s Universal Partnerships (UP) Program.

  • Akili Interactive Labs (Boston) was granted $190,000 for collaboration with Starlab in Barcelona Spain.
  • DetectoGen (Westborough) was granted $200,000 for their work with the Universidade Federal de Minas Gerais in Brazil.
  • LX Medical (Westwood) was granted $70,000 for collaboration with BC Cancer Agency Research Center in Vancouver, Canada.
  • Agile Devices (Cambridge) was granted $100,000 for their work with Agile MV, a company that specializes in catheter-based products in Montreal, Canada.
  • Akrivis Technologies (Salem & Cambridge) was granted $174,705 for collaboration with CEA-Leti in Grenoble France.
  • Revolution Biosciences (Boston) was granted $195,000 for their work with Merck Serono in Darmstadt, Germany.

Read the press release here »

November 25, 2015

ValiRX establishes first US office in Cambridge, MA and strengthens US Advisory Team

United Kingdom-based ValiRx Plc announced the opening of its new North American office in Cambridge, Massachusetts. Located in Kendall Square, the office is the firm’s first North American location. ValiRx is a life science company with a focus on cancer therapeutics and epigenetic cancer diagnostics for personalized medicine.

Read the press release here »

November 19, 2015

Vantix Diagnostics opens new facility in Lowell

vantix DIAGNOSTICS announced today the relocation of its US headquarters to the University of Massachusetts Lowell Innovation Hub.  vantix had been located in New Hampshire yet on the lookout for space within the biotech corridor outside of Boston.

Read the press release here »

November 13, 2015

Jana Care establishes its first operations in the U.S.

Jana Care, a startup company tackling diabetes care in India, is establishing its first full-time U.S. operations in Boston. Recognizing the leadership of the medical and biotechnology community of Greater Boston, Jana Care decided to bring their R&D operations to the Hub. The U.S. office of Jana Care will be based out of the Business Innovation Center at Boston University, and the company has also joined the Harvard Launch Lab.

Read the press release here »

November 3, 2015

Cyclica expands to U.S., opens office in Cambridge, Mass.

Cyclica, a Canadian startup company, with a proprietary Big Data Platform for drug and compound development for human applications, has hired a new chief executive with Massachusetts roots and announced plans to establish its U.S. base in Cambridge, Massachusetts. Toronto-based Cyclica Inc. has hired Paul Angelico, Co-Founder and former President of Twin Rivers Technologies in Quincy, MA, as President and Chief Executive Officer (CEO).

Read the press release here »

October 28, 2015

Life Science Real Estate Developer King Street Properties to Break Ground on a New $45.5 Million Building at 115 Hartwell Avenue in The Hartwell Innovation Campus in Lexington, Massachusetts

King Street Properties, the largest privately held owner of life science real estate in the Greater Boston area, celebrated the groundbreaking of a new $45.5 million life science building at 115 Hartwell Avenue, on its Lexington campus known as The Hartwell Innovation Campus (THINC) on Wednesday, October 28, 2015. State Representative Jay Kaufman, Chairman of the Board of Selectmen for the Town of Lexington Joe Pato, Massachusetts Life Sciences Center CEO Travis McCready, and MassBIO Executive Vice President Sarah MacDonald attended a groundbreaking ceremony to mark this important occasion.

Photo caption: Joe Pato, Chairman of the Board of Selectmen for the Town of Lexington, Jay Kaufman, Massachusetts State Representative, Steve Lynch of King Street Properties, Tom Ragno of King Street Properties Travis McCready, President & CEO of the Massachusetts Life Sciences Center, Sarah MacDonald, Executive Vice President at MassBIO and representatives from Jones Lang LaSalle and Citizens Bank break ground on King Street Properties’ new $45.5 million life science building at 115 Hartwell Avenue in Lexington.

Photo caption: Joe Pato, Chairman of the Board of Selectmen for the Town of Lexington, Jay Kaufman, Massachusetts State Representative, Steve Lynch of King Street Properties, Tom Ragno of King Street Properties Travis McCready, President & CEO of the Massachusetts Life Sciences Center, Sarah MacDonald, Executive Vice President at MassBIO and representatives from Jones Lang LaSalle and Citizens Bank break ground on King Street Properties’ new $45.5 million life science building at 115 Hartwell Avenue in Lexington.

 

Read the press release here »

September 18, 2015

Selvita establishes its first operations in the U.S.

Selvita, the largest drug discovery company in Central and Eastern Europe is establishing its first offices in the United States. Appreciating the importance of the U.S. biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc. The new company will initially have two offices located where the heart of the biotechnology industry beats – in Greater Boston and in the San Francisco Bay areas.

Massachusetts Secretary of Housing and Economic Development Jay Ash welcomes Selvita to the Commonwealth during his speech at Selvita’s reception at the Museum of Science in Boston last evening.

Massachusetts Secretary of Housing and Economic Development Jay Ash welcomes Selvita to the Commonwealth during his speech at Selvita’s reception at the Museum of Science in Boston last evening.

Read the press release here »

September 11, 2015

Applied Photophysics Opens First North American Facility in Beverly

United Kingdom-based Applied Photophysics (APL) today announced the grand opening of its new North American Demonstration Lab at Cummings Center in Beverly, Massachusetts. The 2,400-square-foot space is the global firm’s first North American location.

(From left to right) Jeff Dillon, Vice Consul-Trade & Investment Officer at the British Consulate-General Boston, Sharon Polleck, Research Scientist at Pfizer Pharmaceuticals, Mike Kennealy, Acting President and CEO of the MLSC, Laura Hamilton, Manager of Member Recruitment at MassBio and Louise Madden, Chief Operating Officer at Applied Photophysics participate in a ribbon cutting to celebrate the official opening of Applied Photophysics’ first North American facility in Beverly.

(From left to right) Jeff Dillon, Vice Consul-Trade & Investment Officer at the British Consulate-General Boston, Sharon Polleck, Research Scientist at Pfizer Pharmaceuticals, Mike Kennealy, Acting President and CEO of the MLSC, Laura Hamilton, Manager of Member Recruitment at MassBio and Louise Madden, Chief Operating Officer at Applied Photophysics participate in a ribbon cutting to celebrate the official opening of Applied Photophysics’ first North American facility in Beverly.

Read the press release here »

July 29, 2015

Fiore Healthcare Advisors opens new office in Cambridge

Fiore Healthcare Advisors LLC (FHA), a Pharmacovigilance and Clinical Research consultancy, announced the opening of its newest office in the biopharmaceutical hub of Cambridge, Massachusetts.  Founded in New Jersey, the firm has opened a Cambridge office in order to better serve its clients in the Greater Boston area.

Read the press release here »

July 9, 2015

Massachusetts Life Sciences Center and CASIS Announce Winners of Space Station STEM Challenge

The Massachusetts Life Sciences Center (MLSC) and the Center for the Advancement of Science in Space (CASIS) announced the winners of the Space Station STEM Challenge, a $50,000 grant competition that allowed Massachusetts middle schools to compete for resources to send a life sciences research experiment to the International Space Station (ISS) U.S. National Laboratory. Talbot Innovation Middle School in Fall River, MA and Collins Middle School in Salem, MA were announced as winners, and both schools will participate in a joint experiment focused on tadpole morphology and developmental abnormalities in frogs.

Fall River STEM Challenge Winners

NASA Astronaut Cady Coleman (far left), 8th Grade Technology and Engineering teacher at Talbot Innovation Middle School in Fall River Benjamin Coleman (center), Manager of for Academic and Workforce Programs Ryan Mudawar (far right) and students from Talbot Innovation Middle School participated in the announcement of the Space Station STEM Challenge winners at the ISS R&D Conference in Boston.

Salem STEM Challenge Runner Up

NASA Astronaut Cady Coleman (far left), STEM teacher at Collins Middle School in Salem Matthew Weaver (left of center), Manager of for Academic and Workforce Programs Ryan Mudawar (far right) and students from Collins Middle School participated in the announcement of the Space Station STEM Challenge winners at the ISS R&D Conference in Boston.

Read the press release here »

July 7, 2015

Governor Baker, Massachusetts Life Sciences Center and CASIS Announce Winners of Galactic Grant Competition

Massachusetts Governor Charlie Baker, The Center for the Advancement of Science in Space (CASIS) and the Massachusetts Life Sciences Center (MLSC) announced grant awards for two Massachusetts-based life science companies, totaling $500,000 in funding as part of the Galactic Grant Competition.  The winners were announced at the 2015 ISS R&D Conference, taking place this year in Boston. The winning companies are Nanobiosym, Inc. and Zaiput Flow Technologies, both located in Cambridge. The grant funding will allow Zaiput and Nanobiosym to leverage up to $7.4 million per project of support from CASIS to fly their projects up to station, conduct their projects on station, and bring the experiments back to earth.

(From left to right) Interim CEO Mike Kennealy, Governor Charlie Baker, Chairman and CEO of Nanobiosym Dr. Anita Goel, NASA Astronaut Cady Coleman, Co-founder and CEO of Zaiput Flow Technologies Dr. Andrea Adamo, Head of the ISS for NASA Mike Suffredini, Chief Scientist at the ISS Station for NASA, Former NASA Astronaut and Executive Director of CASIS Gregory Johnson and President of the American Astronautical Society Lyn D. Wigbels participate in the the announcement of the Galactic Grant Competition winners at the ISS R&D Conference in Boston.

(From left to right) Interim CEO Mike Kennealy, Governor Charlie Baker, Chairman and CEO of Nanobiosym Dr. Anita Goel, NASA Astronaut Cady Coleman, Co-founder and CEO of Zaiput Flow Technologies Dr. Andrea Adamo, Head of the ISS for NASA Mike Suffredini, Chief Scientist at the ISS Station for NASA, Former NASA Astronaut and Executive Director of CASIS Gregory Johnson and President of the American Astronautical Society Lyn D. Wigbels participate in the the announcement of the Galactic Grant Competition winners at the ISS R&D Conference in Boston.

Read the press release here »

Connect With Us

Facebook LinkedIn Twitter